26 phenotypes from 3 alleles in 5 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
Retnlbtm1Gdw/Retnlbtm1Gdw involves: 129S/SvEv * C57BL/6	decreased inflammatory response	J:114507
	decreased susceptibility to induced colitis	J:114507
	decreased susceptibility to induced morbidity/mortality	J:114507
	decreased susceptibility to injury	J:114507
Retnlbtm1Lex/Retnlbtm1Lex B6.129S5-Retnlbtm1Lex	abnormal colon morphology	J:235058
	decreased incidence of tumors by chemical induction	J:235058
	normal growth/size/body region phenotype	J:235058
	impaired glucose tolerance	J:235058
Retnlbtm1Lex/Retnlbtm1Lex FVB.129S5-Retnlbtm1Lex	abnormal CD4-positive, alpha-beta T cell physiology	J:235058
	abnormal colon morphology	J:235058
	decreased circulating interleukin-6 level	J:235058
	enlarged liver	J:235058
	impaired glucose tolerance	J:235058
	increased body weight	J:235058
	increased circulating interleukin-13 level	J:235058
	increased incidence of tumors by chemical induction	J:235058
	increased mesenteric fat pad weight	J:235058
	increased neutrophil cell number	J:235058
	liver inflammation	J:235058
	white adipose tissue inflammation	J:235058
Retnlbtm1Mer/Retnlbtm1Mer involves: 129S1/Sv	decreased IgG2a level	J:141446
	decreased interferon-gamma secretion	J:141446
	decreased susceptibility to parasitic infection	J:141446
	decreased tumor necrosis factor secretion	J:141446
	increased IgG1 level	J:141446
Retnlbtm1Mer/Retnlbtm1Mer involves: 129S1/Sv * C57BL/6	abnormal digestive system physiology	J:141524
	abnormal intestinal epithelium morphology	J:141524
	decreased susceptibility to induced colitis	J:141524
	increased susceptibility to induced colitis	J:141524